Atlas Trials

Examine Maximum Tolerated Dose and Pharmacokinetic and Pharmacodynamic Profile

Clinical trial NCT01226407 · UNKNOWN

Trial details

NCT number
NCT01226407
Sponsor
CrystalGenomics, Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumour
Start date
2010-09-01
Primary completion
2013-02-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.